RxDoctor Payments DataLook up a doctor →

Chad Gorman, MD

Sports Medicine · New Port Richey, FLNPI 1659507507

Payments from drug & device makers

$41,538in general payments, 2019–2025

Across 915 payments — averaging $45.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$23K
  • Nutech Spine, Inc.$5K
  • Medtronic$2K
  • Collegium Pharmaceutical, Inc.$2K
  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • plus $7K from 42 others

What the payments were for

  • Consulting fees$4,20010%
  • Speaking & faculty fees$7,74019%
  • Travel & lodging$5,86914%
  • Food & beverage$23,39556%
  • Education$1080%
  • Gifts$00%
  • Entertainment$2261%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,538 in reported general payments places this provider in the 90th percentile of 402 sports medicine providers in Florida.

See all sports medicine providers in Florida

Medicare billing

Part B allowed, 2024
$373,181
Medicare patients
484
Services billed
12,553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate550$229,598
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,733$109,843
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,372$73,092
Oxycodone Hcl3,281$68,131
Morphine Sulfate ErMorphine Sulfate2,040$48,127
BelbucaBuprenorphine Hcl34$18,836
Morphine Sulfate430$15,254
OxycontinOxycodone Hcl38$14,199
Hysingla ErHydrocodone Bitartrate33$12,399
MovantikNaloxegol Oxalate28$10,864
Hydromorphone Hcl413$9,051
Pregabalin305$7,879
Lubiprostone63$7,669
Fentanyl56$5,381
Buprenorphine15$4,904

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$1,555$248,434584 claims
Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine, Buprenorphine Hcl, Buprenorphine-Naloxone$35$25,017534 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 402 sports medicine providers in Florida.

Other sports medicine in New Port Richey

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →